Haemostasis, or maintaining an exact balance between bleeding and blood clotting, is our main focus. In order to shed light on the interactions between blood platelets and important coagulation factors and proteins involved in fibrinolysis, we employ a range of different laboratory methods.

Our clinical perspective is to provide the best possible diagnosis, and we work with clinical studies involving a variety of patient groups, studies to develop and improve methods, as well as studies to enhance diagnostic strategies. Studies include, among others, critically ill patients, cancer patients and patients with ischemic heart diseases and venous thrombosis.

In the Thrombosis and Haemostasis Research Group several specialised laboratory analyses are performed:

• Thromboelastometry
• Platelet function analyses
• Flow cytometry analyses of platelets
• Thrombin generation
• Turbidimetric clot-lysis-assay
• Analysis of micro-RNA expression
• A range of different ELISA-assays: thrombin-antithrombin complex, plasminogen-activator-inhibitor 1 (PAI-1), tissue type activator, prothrombin fragment 1+2, trombomodulin, TAFI, p-selectin, e-selectin, tromboxan, syndecan a.